US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

19.75

-0.4600-2.28%

Post-market: 19.75-0.0480-0.24%18:24 EDT

Volume:2.46M

Turnover:48.00M

Market Cap:2.22B

PE:-10.68

High:20.40

Open:20.21

Low:18.60

Close:20.21

Loading ...

Overview Company News Filings

NewAmsterdam Pharma Is Maintained at Buy by Needham

NewAmsterdam Pharma Q1 Net Loss Narrows, Revenue Rises

MT Newswires Live

NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings Summary

NewAmsterdam Pharma Q1 EPS $(0.34) Beats $(0.48) Estimate, Sales $2.98M Beat $1.58M Estimate

Earnings Flash (NAMS) NewAmsterdam Pharma Posts Q1 Comprehensive Loss $39.6M

MT Newswires Live

Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NewAmsterdam Pharma Announces Inducement Grants for New Hires Under 2024 Plan

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress

Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

NewAmsterdam Pharma Company (NAMS) Receives a Buy from TD Cowen

NewAmsterdam Pharma Price Target Maintained With a $42.00/Share by Needham

Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Piper Sandler Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

William Blair Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference

NewAmsterdam Pharma Company Nv : Guggenheim Raises Target Price to $41 From $35

THOMSON REUTERS

NewAmsterdam Pharma files $500M mixed securities shelf

Analysts Offer Insights on Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Organogenesis Holdings (ORGO)

NewAmsterdam Pharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NAMS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":19.75,"timestamp":1750104000000,"preClose":20.21,"halted":0,"volume":2459009,"hourTrading":{"tag":"盘后","latestPrice":19.75,"preClose":19.798,"latestTime":"18:24 EDT","volume":775381,"amount":15313778.9,"timestamp":1750112655488},"delay":0,"floatShares":54411848,"shares":112270677,"eps":-1.849641,"marketStatus":"Not Yet Opened","change":-0.46,"latestTime":"06-16 16:00:00 EDT","open":20.21,"high":20.4,"low":18.6,"amount":48001549.937201,"amplitude":0.089065,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.849641,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750147200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":20.21,"preHourTrading":{"tag":"盘前","latestPrice":20.25,"preClose":20.21,"latestTime":"09:27 EDT","volume":687,"amount":14082.396678000001,"timestamp":1750080460062},"postHourTrading":{"tag":"盘后","latestPrice":19.75,"preClose":19.798,"latestTime":"18:24 EDT","volume":775381,"amount":15313778.9,"timestamp":1750112655488},"volumeRatio":2.274543,"impliedVol":0.7707,"impliedVolPercentile":0.4458},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","floatShares":54411848,"roa":"-18.15%","roe":"-31.51%","lyrEps":-2.560438,"volumeRatio":2.274543,"shares":112270677,"dividePrice":0,"high":20.4,"amplitude":0.089065,"preClose":20.21,"low":18.6,"week52Low":14.06,"pbRate":"2.85","psRate":"47.04","week52High":27.29,"institutionHeld":0,"latestPrice":19.75,"eps":-1.849641,"divideRate":0,"volume":2459009,"delay":0,"ttmEps":-1.849641,"open":20.21,"prevYearClose":25.7,"prevWeekClose":20.21,"prevMonthClose":18.11,"prevQuarterClose":20.47,"fiveDayClose":20.16,"twentyDayClose":18.88,"sixtyDayClose":24.07},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534168426","title":"NewAmsterdam Pharma Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2534168426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534168426?lang=en_us&edition=fundamental","pubTime":"2025-05-09 03:05","pubTimestamp":1746731100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2025 15:05 ET (19:05 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2533013476","title":"NewAmsterdam Pharma Q1 Net Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2533013476","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533013476?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:21","pubTimestamp":1746714102,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma  shares were down 1% on Thursday after reporting a Q1 net loss of $0.34 per diluted share, narrowing from a $1.06 loss a year earlier.Analysts polled by FactSet expected a $0.50 loss.Revenue for the quarter ended March 31 was $3 million, up from $1.4 million a year earlier.Analysts expected $1.6 million.The Dutch biopharmaceutical company had cash and equivalents of $808.5 million at end of Q1 compared with $834.2 million on hand on Dec. 31, 2024.Price: 18.08, Change: -0.84, Percent Change: -4.44","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAMS"],"gpt_icon":0},{"id":"2533365061","title":"NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533365061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533365061?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:48","pubTimestamp":1746712089,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings SummaryNewAmsterdam Pharma Company NV NAMS.OQ reported a quarterly adjusted loss of 34 cents per share for the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG264:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2533118411","title":"NewAmsterdam Pharma Q1 EPS $(0.34) Beats $(0.48) Estimate, Sales $2.98M Beat $1.58M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533118411","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533118411?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:13","pubTimestamp":1746706424,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.48) by 29.17 percent.  The company reported quarterly sales of $2.98 million which beat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45283370/newamsterdam-pharma-q1-eps-0-34-beats-0-48-estimate-sales-2-98m-beat-1-58m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2533018413","title":"Earnings Flash (NAMS) NewAmsterdam Pharma Posts Q1 Comprehensive Loss $39.6M","url":"https://stock-news.laohu8.com/highlight/detail?id=2533018413","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533018413?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:11","pubTimestamp":1746706302,"startTime":"0","endTime":"0","summary":"Earnings Flash (NAMS) NewAmsterdam Pharma Posts Q1 Comprehensive Loss $39.6M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAMS"],"gpt_icon":0},{"id":"2533184973","title":"Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533184973","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533184973?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:00","pubTimestamp":1746705600,"startTime":"0","endTime":"0","summary":"-- EMA submission expected in 2H25 by partner Menarini --. -- BROADWAY and TANDEM results presented at EAS with simultaneous publications in the New England Journal of Medicine and The Lancet, respectively --. -- Company to host R&D day on June 11 , 2025 in New York City --. \"Our first quarter was marked by continued clinical execution and investment in our commercial organization to support the potential launch of obicetrapib,\" said Michael Davidson, M.D., Chief Executive Officer of NewAmsterdam. \"With over $800 million in cash, cash equivalents and marketable securities on our balance sheet, we believe we are well positioned to drive near- and long-term value for our stakeholders, as we move closer to delivering novel, once-daily, low dose, oral therapies to address the significant global unmet need for safe and effective LDL-C lowering therapies.\". NewAmsterdam is developing obicetrapib, an oral, low-dose, once-daily, highly-selective cholesteryl ester transfer protein  inhibitor, a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2532687157","title":"NewAmsterdam Pharma Announces Inducement Grants for New Hires Under 2024 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2532687157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532687157?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:01","pubTimestamp":1746216072,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company N.V., a clinical biopharmaceutical company focused on developing oral, non-statin medicines for cardiovascular disease, announced the approval of inducement share options for eleven new non-executive employees. The grants, totaling 197,000 of NewAmsterdam's ordinary shares, are part of the 2024 Inducement Plan, in compliance with Nasdaq Listing Rule 5635. The share options have an exercise price of $20.03, reflecting the closing market price as of May 1, 2025. The vesting schedule includes 25% of the shares vesting on the one-year anniversary of the vesting commencement date, with the remainder vesting over the following 36 months, contingent on continued service with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nNDLbBwYbz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","LU2095319765.USD","LU2210149790.SGD","BK4588","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NAMS","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139"],"gpt_icon":0},{"id":"2532879082","title":"NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2532879082","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532879082?lang=en_us&edition=fundamental","pubTime":"2025-05-03 04:01","pubTimestamp":1746216060,"startTime":"0","endTime":"0","summary":"NAARDEN, the Netherlands and MIAMI, May 02, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 197,000 of NewAmsterdam’s ordinary shares to eleven non-executive new hires. The share options were granted as an inducement material to the employees’ acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan  and in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-reports-inducement-grants-200100213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","BK4585","LU2210149790.SGD","LU2210150020.SGD","NAMS","BK4112","BK4139","NDAQ","IE00B3QW5Z07.USD","NAMSW","IE00BGHQF748.EUR",".IXIC","IE00BKPKM429.USD","BK4588","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2531039458","title":"NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2531039458","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531039458?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:00","pubTimestamp":1746014400,"startTime":"0","endTime":"0","summary":"Presentations include new data from BROADWAY and TANDEM Phase 3 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers. Title: Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular RiskSession Name: Late Breaker Session: ClinicalOral Presentation Date and Time: Wednesday, May 5, 2025, 12:15-12:30 PM BST Location: Will Harvey Hall","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-present-clinical-preclinical-120000593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAMSW","NAMS","HDL","BK4209"],"gpt_icon":0},{"id":"2528778005","title":"Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2528778005","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528778005?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:01","pubTimestamp":1744920060,"startTime":"0","endTime":"0","summary":"NAARDEN, the Netherlands and MIAMI, April 17, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced the appointment of Adele Gulfo as an independent director to its Board of Directors. Ms. Gulfo is an established pharmaceutical leader with over three decades of experience in the healthcare industry, distinguished by her expertise in global strategy, operations leadership, and the commercialization of multiple blockbuster medicines including LIPITOR and CRESTOR .","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU1894683348.USD","LU1894683264.USD","IE0002270589.USD","IE00BLSP4452.SGD","LU1883839398.USD","LU0122379950.USD","SG9999001176.USD","LU0868494617.USD","LU0985481810.HKD","LU1023059063.AUD","NAMS","BK4232","LU0321505439.SGD","BK4534","BK4592","BK4568","LU1066051498.USD","LU0306806265.USD","IE000M9KFDE8.USD","SG9999001176.SGD","SG9999011175.SGD","BK4585","SG9999002232.USD","IE00BLSP4239.USD","BK4139","LU0234572021.USD","SG9999013999.USD","LU1066053197.SGD","BK4599","BK4588","BK4022","LU0058720904.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU1057294990.SGD","BK4007","R","LU0306807586.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0456855351.SGD","BK4533","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0225284248.USD","LU0321505868.SGD","LU0170899867.USD","SG9999002224.SGD"],"gpt_icon":1},{"id":"2526368467","title":"NewAmsterdam Pharma Company (NAMS) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2526368467","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526368467?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:46","pubTimestamp":1744199213,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tyler Van Buren maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today. The company’s shares closed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/newamsterdam-pharma-company-nams-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/newamsterdam-pharma-company-nams-receives-a-buy-from-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS","BK4585","BK4139","TD","BK4566","COWN","BK4127","BK4207"],"gpt_icon":0},{"id":"2525892761","title":"NewAmsterdam Pharma Price Target Maintained With a $42.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2525892761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525892761?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:58","pubTimestamp":1744117080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 08, 2025 08:58 ET (12:58 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2525730082","title":"Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525730082","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525730082?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:41","pubTimestamp":1743799292,"startTime":"0","endTime":"0","summary":"April 4 (Reuters) - NewAmsterdam Pharma Company NV ::*NEWAMSTERDAM PHARMA REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 04-APR-202520:01:00.033 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nRSDcf23JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2524912194","title":"Piper Sandler Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524912194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524912194?lang=en_us&edition=fundamental","pubTime":"2025-04-01 18:46","pubTimestamp":1743504383,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS"],"gpt_icon":0},{"id":"2524313138","title":"William Blair Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524313138","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524313138?lang=en_us&edition=fundamental","pubTime":"2025-04-01 10:45","pubTimestamp":1743475508,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today. The company’s shares close...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-newamsterdam-pharma-company-nams?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-newamsterdam-pharma-company-nams?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS"],"gpt_icon":0},{"id":"2523394569","title":"NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2523394569","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523394569?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422400,"startTime":"0","endTime":"0","summary":"NAARDEN, the Netherlands and MIAMI, March 31, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced that Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma, will participate in a virtual fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025 at 12:45 p.m. ET.NewAmsterdam Pharma  is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple phase 3 trials, NewAmsterdam is investigating obicetrapib, an oral, low-dose and on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-present-24th-annual-120000808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4137","NAMSW","HCSG","NAMS"],"gpt_icon":0},{"id":"2516682188","title":"NewAmsterdam Pharma Company Nv : Guggenheim Raises Target Price to $41 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2516682188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516682188?lang=en_us&edition=fundamental","pubTime":"2025-03-03 19:41","pubTimestamp":1741002063,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nFWN3PM0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2516300845","title":"NewAmsterdam Pharma files $500M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2516300845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516300845?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:10","pubTimestamp":1740780628,"startTime":"0","endTime":"0","summary":"17:07 EST NewAmsterdam Pharma (NAMS) files $500M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-movin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-files-500m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-files-500m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2514362946","title":"Analysts Offer Insights on Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Organogenesis Holdings (ORGO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514362946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514362946?lang=en_us&edition=fundamental","pubTime":"2025-02-28 10:30","pubTimestamp":1740709809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NewAmsterdam Pharma Company (NAMS – Research Report)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-newamsterdam-pharma-company-nams-and-organogenesis-holdings-orgo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-newamsterdam-pharma-company-nams-and-organogenesis-holdings-orgo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","ORGO","HCSG","NAMS","BK4139"],"gpt_icon":0},{"id":"2514082178","title":"NewAmsterdam Pharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2514082178","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514082178?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:19","pubTimestamp":1740655168,"startTime":"0","endTime":"0","summary":"NasdaqGM:NAMS Earnings and Revenue Growth February 27th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 39%. Earnings per share  missed analyst estimates by 24%.Looking ahead, revenue is forecast to grow 56% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Biotechs industry in the US.The company's shares are up 3.7% from a week ago.You should learn about the   3 warning signs  we've spotted with NewAmsterdam Pharma.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-full-2024-earnings-111928524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAMSW","NAMS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":63,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":12,"updateTime":1749700800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAMS","date":"2025-06-13","current":-12.601823,"percent":0.396067,"low":-24.522784,"twenty":-21.102061,"median":-11.009662,"eighty":-4.386985,"high":37.547018,"avg":-9.796734,"sd":12.766528,"marketCap":2361052337},"quantilePoints":[{"date":"2021-02-12","current":-21.838475,"twenty":-21.935278,"median":-21.828934,"eighty":-21.349311,"marketCap":152162640},{"date":"2021-02-19","current":-21.896664,"twenty":-21.861751,"median":-21.619037,"eighty":-21.46054,"marketCap":152734680},{"date":"2021-02-26","current":-21.012022,"twenty":-21.861751,"median":-21.551533,"eighty":-21.347758,"marketCap":146156220},{"date":"2021-03-05","current":-21.131171,"twenty":-21.83275,"median":-21.378316,"eighty":-21.121888,"marketCap":144726120},{"date":"2021-03-12","current":-21.057477,"twenty":-21.702996,"median":-21.336928,"eighty":-21.039295,"marketCap":144583110},{"date":"2021-03-19","current":-20.921405,"twenty":-21.589261,"median":-21.248455,"eighty":-20.956826,"marketCap":143153010},{"date":"2021-03-26","current":-20.670206,"twenty":-21.547958,"median":-21.13039,"eighty":-20.79868,"marketCap":140149800},{"date":"2021-04-01","current":-20.845813,"twenty":-21.531241,"median":-21.121823,"eighty":-20.817601,"marketCap":141007860},{"date":"2021-04-09","current":-21.225903,"twenty":-21.467898,"median":-21.109261,"eighty":-20.79095,"marketCap":145012140},{"date":"2021-04-16","current":-20.537749,"twenty":-21.367336,"median":-21.07922,"eighty":-20.761675,"marketCap":141436890},{"date":"2021-04-23","current":-20.315019,"twenty":-21.347758,"median":-20.984107,"eighty":-20.655391,"marketCap":140864850},{"date":"2021-04-30","current":-20.575716,"twenty":-21.338162,"median":-20.952872,"eighty":-20.552936,"marketCap":142294950},{"date":"2021-05-07","current":-20.262992,"twenty":-21.300508,"median":-20.893278,"eighty":-20.441966,"marketCap":141579900},{"date":"2021-05-14","current":-20.126121,"twenty":-21.252461,"median":-20.822297,"eighty":-20.370365,"marketCap":140435820},{"date":"2021-05-21","current":-20.063477,"twenty":-21.239434,"median":-20.785932,"eighty":-20.317104,"marketCap":140578830},{"date":"2021-05-28","current":-9.074203,"twenty":-21.215604,"median":-20.72844,"eighty":-20.270407,"marketCap":63580250},{"date":"2021-06-04","current":-9.099058,"twenty":-21.186359,"median":-20.671226,"eighty":-20.246426,"marketCap":63645797},{"date":"2021-06-11","current":-20.256213,"twenty":-21.131171,"median":-20.62297,"eighty":-20.108533,"marketCap":140864850},{"date":"2021-06-18","current":-20.772768,"twenty":-21.130859,"median":-20.59844,"eighty":-20.118,"marketCap":141579900},{"date":"2021-06-25","current":-20.724223,"twenty":-21.128116,"median":-20.62297,"eighty":-20.123197,"marketCap":142294950},{"date":"2021-07-02","current":-20.626893,"twenty":-21.122017,"median":-20.616149,"eighty":-20.125343,"marketCap":140435820},{"date":"2021-07-09","current":-20.380574,"twenty":-21.1215,"median":-20.614557,"eighty":-20.126121,"marketCap":139005720},{"date":"2021-07-16","current":-20.519425,"twenty":-21.109261,"median":-20.575716,"eighty":-20.156594,"marketCap":139291740},{"date":"2021-07-23","current":-20.512371,"twenty":-21.100962,"median":-20.537878,"eighty":-20.242284,"marketCap":138719700},{"date":"2021-07-30","current":-20.299111,"twenty":-21.057477,"median":-20.519425,"eighty":-20.242284,"marketCap":138433680},{"date":"2021-08-06","current":-20.554664,"twenty":-21.012022,"median":-20.514719,"eighty":-20.242284,"marketCap":139005720},{"date":"2021-08-13","current":-20.447221,"twenty":-20.984107,"median":-20.517067,"eighty":-20.256213,"marketCap":138719700},{"date":"2021-08-20","current":-20.697321,"twenty":-20.975132,"median":-20.51883,"eighty":-20.262992,"marketCap":139005720},{"date":"2021-08-27","current":-20.379723,"twenty":-20.972644,"median":-20.518236,"eighty":-20.265529,"marketCap":138147660},{"date":"2021-09-03","current":-20.932843,"twenty":-20.9331,"median":-20.51883,"eighty":-20.267469,"marketCap":143010000},{"date":"2021-09-10","current":-20.672351,"twenty":-20.952117,"median":-20.526525,"eighty":-20.273344,"marketCap":140578830},{"date":"2021-09-17","current":-20.788911,"twenty":-20.935877,"median":-20.538007,"eighty":-20.294251,"marketCap":140292810},{"date":"2021-09-24","current":-20.925132,"twenty":-20.932894,"median":-20.56006,"eighty":-20.301276,"marketCap":140864850},{"date":"2021-10-01","current":-21.007107,"twenty":-20.973142,"median":-20.575716,"eighty":-20.306471,"marketCap":140006790},{"date":"2021-10-08","current":-21.151111,"twenty":-21.00809,"median":-20.581853,"eighty":-20.310016,"marketCap":140721840},{"date":"2021-10-15","current":-20.992495,"twenty":-21.033503,"median":-20.614435,"eighty":-20.314138,"marketCap":140006790},{"date":"2021-10-22","current":-20.979254,"twenty":-21.015601,"median":-20.620294,"eighty":-20.319189,"marketCap":140292810},{"date":"2021-10-29","current":-21.103709,"twenty":-21.049534,"median":-20.628022,"eighty":-20.340912,"marketCap":140292810},{"date":"2021-11-05","current":-21.161406,"twenty":-21.059496,"median":-20.645111,"eighty":-20.350832,"marketCap":140578830},{"date":"2021-11-12","current":-21.337744,"twenty":-21.068902,"median":-20.670206,"eighty":-20.353037,"marketCap":140435820},{"date":"2021-11-19","current":-21.577137,"twenty":-21.091056,"median":-20.678231,"eighty":-20.353298,"marketCap":140435820},{"date":"2021-11-26","current":-21.52096,"twenty":-21.108578,"median":-20.693694,"eighty":-20.355018,"marketCap":140006790},{"date":"2021-12-03","current":-21.5525,"twenty":-21.125131,"median":-20.706276,"eighty":-20.35641,"marketCap":139863780},{"date":"2021-12-10","current":-21.569806,"twenty":-21.155229,"median":-20.729118,"eighty":-20.357488,"marketCap":140292810},{"date":"2021-12-17","current":-21.444455,"twenty":-21.18744,"median":-20.755321,"eighty":-20.360981,"marketCap":139005720},{"date":"2021-12-23","current":-21.411047,"twenty":-21.239434,"median":-20.778281,"eighty":-20.367381,"marketCap":139291740},{"date":"2021-12-31","current":-21.326314,"twenty":-21.328981,"median":-20.793694,"eighty":-20.376349,"marketCap":139434750},{"date":"2022-01-07","current":-21.496624,"twenty":-21.347524,"median":-20.831373,"eighty":-20.380063,"marketCap":140149800},{"date":"2022-01-14","current":-21.343042,"twenty":-21.350709,"median":-20.845796,"eighty":-20.384765,"marketCap":140149800},{"date":"2022-01-21","current":-21.439355,"twenty":-21.390606,"median":-20.871892,"eighty":-20.394177,"marketCap":139792275},{"date":"2022-01-28","current":-21.81807,"twenty":-21.411007,"median":-20.878577,"eighty":-20.407434,"marketCap":140006790},{"date":"2022-02-04","current":-21.195343,"twenty":-21.415476,"median":-20.901854,"eighty":-20.412214,"marketCap":139434750},{"date":"2022-02-11","current":-21.331112,"twenty":-21.429778,"median":-20.921405,"eighty":-20.419903,"marketCap":139863780},{"date":"2022-02-18","current":-21.489301,"twenty":-21.43906,"median":-20.931009,"eighty":-20.423447,"marketCap":140006790},{"date":"2022-02-25","current":-21.593859,"twenty":-21.452754,"median":-20.936467,"eighty":-20.427355,"marketCap":139863780},{"date":"2022-03-04","current":-22.31244,"twenty":-21.464918,"median":-20.972644,"eighty":-20.428933,"marketCap":140006790},{"date":"2022-03-11","current":-22.266973,"twenty":-21.496624,"median":-20.979146,"eighty":-20.432589,"marketCap":140149800},{"date":"2022-03-18","current":-22.060307,"twenty":-21.513575,"median":-20.987624,"eighty":-20.434714,"marketCap":140292810},{"date":"2022-03-25","current":-22.254443,"twenty":-21.52344,"median":-20.998804,"eighty":-20.447221,"marketCap":140578830},{"date":"2022-04-01","current":-22.154187,"twenty":-21.542769,"median":-21.012022,"eighty":-20.451813,"marketCap":140578830},{"date":"2022-04-08","current":-22.481854,"twenty":-21.567321,"median":-21.030475,"eighty":-20.452843,"marketCap":140578830},{"date":"2022-04-14","current":-22.67216,"twenty":-21.569768,"median":-21.052463,"eighty":-20.467141,"marketCap":140864850},{"date":"2022-04-22","current":-22.730966,"twenty":-21.579562,"median":-21.057477,"eighty":-20.474288,"marketCap":140864850},{"date":"2022-04-29","current":-23.274023,"twenty":-21.614609,"median":-21.067729,"eighty":-20.476303,"marketCap":141007860},{"date":"2022-05-06","current":-23.127906,"twenty":-21.66066,"median":-21.076365,"eighty":-20.478189,"marketCap":140864850},{"date":"2022-05-13","current":-23.491752,"twenty":-21.687663,"median":-21.09477,"eighty":-20.47859,"marketCap":140578830},{"date":"2022-05-20","current":-23.178757,"twenty":-21.820243,"median":-21.108122,"eighty":-20.48606,"marketCap":140578830},{"date":"2022-05-27","current":-22.893849,"twenty":-21.850993,"median":-21.120918,"eighty":-20.491024,"marketCap":141007860},{"date":"2022-06-03","current":-22.874754,"twenty":-21.920045,"median":-21.125878,"eighty":-20.495924,"marketCap":140950656},{"date":"2022-06-10","current":-23.37928,"twenty":-22.019208,"median":-21.131171,"eighty":-20.503856,"marketCap":141436890},{"date":"2022-06-17","current":-23.535903,"twenty":-22.073973,"median":-21.161634,"eighty":-20.508764,"marketCap":141579900},{"date":"2022-06-24","current":-23.228366,"twenty":-22.168168,"median":-21.177519,"eighty":-20.510788,"marketCap":140864850},{"date":"2022-07-01","current":-23.628446,"twenty":-22.205389,"median":-21.200156,"eighty":-20.514249,"marketCap":141293880},{"date":"2022-07-08","current":-24.122583,"twenty":-22.267227,"median":-21.212539,"eighty":-20.517301,"marketCap":141150870},{"date":"2022-07-15","current":-24.331277,"twenty":-22.320478,"median":-21.237179,"eighty":-20.518474,"marketCap":141150870},{"date":"2022-07-22","current":-24.090008,"twenty":-22.423227,"median":-21.257719,"eighty":-20.52015,"marketCap":141579900},{"date":"2022-07-29","current":-24.168576,"twenty":-22.534118,"median":-21.31615,"eighty":-20.524441,"marketCap":141722910},{"date":"2022-08-05","current":-4.879205,"twenty":-22.582014,"median":-21.326314,"eighty":-20.52015,"marketCap":141722910},{"date":"2022-08-12","current":-4.837995,"twenty":-22.549115,"median":-21.276097,"eighty":-20.510261,"marketCap":141865920},{"date":"2022-08-19","current":-4.945659,"twenty":-22.534118,"median":-21.248455,"eighty":-20.488701,"marketCap":142008930},{"date":"2022-08-26","current":-4.973006,"twenty":-22.502765,"median":-21.218542,"eighty":-20.475462,"marketCap":142151940},{"date":"2022-09-02","current":-4.964584,"twenty":-22.470606,"median":-21.200156,"eighty":-20.448139,"marketCap":142437960},{"date":"2022-09-09","current":-4.95567,"twenty":-22.425612,"median":-21.178962,"eighty":-20.428933,"marketCap":142296380},{"date":"2022-09-16","current":-4.974555,"twenty":-22.424465,"median":-21.161634,"eighty":-20.410452,"marketCap":142580970},{"date":"2022-09-23","current":-5.117324,"twenty":-22.418277,"median":-21.131171,"eighty":-20.379723,"marketCap":142294950},{"date":"2022-09-30","current":-5.084236,"twenty":-22.409269,"median":-21.125878,"eighty":-20.356574,"marketCap":142580970},{"date":"2022-10-07","current":-5.099691,"twenty":-22.388089,"median":-21.120336,"eighty":-20.35202,"marketCap":142580970},{"date":"2022-10-14","current":-5.125907,"twenty":-22.322487,"median":-21.105916,"eighty":-20.310612,"marketCap":142866990},{"date":"2022-10-21","current":4.123596,"twenty":-22.31244,"median":-21.088579,"eighty":-20.274813,"marketCap":143153010},{"date":"2022-10-28","current":4.07957,"twenty":-22.287254,"median":-21.074661,"eighty":-20.256213,"marketCap":143582040},{"date":"2022-11-04","current":4.09622,"twenty":-22.281341,"median":-21.06757,"eighty":-20.156594,"marketCap":143725050},{"date":"2022-11-11","current":3.835525,"twenty":-22.267291,"median":-21.05741,"eighty":-20.116823,"marketCap":140221305},{"date":"2022-11-18","current":3.965158,"twenty":-22.266973,"median":-21.047582,"eighty":-20.01593,"marketCap":145441170},{"date":"2022-11-25","current":22.070496,"twenty":-22.256949,"median":-21.02751,"eighty":-19.909786,"marketCap":812319096},{"date":"2022-12-02","current":18.678955,"twenty":-22.224077,"median":-21.009565,"eighty":-9.20741,"marketCap":693258130},{"date":"2022-12-09","current":20.55276,"twenty":-22.194292,"median":-20.992495,"eighty":-9.076373,"marketCap":766661932},{"date":"2022-12-16","current":23.284761,"twenty":-22.183606,"median":-20.985866,"eighty":-5.170387,"marketCap":873913042},{"date":"2022-12-23","current":24.514364,"twenty":-22.180369,"median":-20.979037,"eighty":-5.136784,"marketCap":921625514},{"date":"2022-12-30","current":23.500927,"twenty":-22.176953,"median":-20.972644,"eighty":-5.116761,"marketCap":889001602},{"date":"2023-01-06","current":25.713628,"twenty":-22.168168,"median":-20.939833,"eighty":-5.097544,"marketCap":965994034},{"date":"2023-01-13","current":21.766355,"twenty":-22.156426,"median":-20.931009,"eighty":-5.061828,"marketCap":833540951},{"date":"2023-01-20","current":21.475872,"twenty":-22.142244,"median":-20.923268,"eighty":-5.030111,"marketCap":823753778},{"date":"2023-01-27","current":34.556535,"twenty":-22.087638,"median":-20.91043,"eighty":-4.995999,"marketCap":1327793218},{"date":"2023-02-03","current":27.072439,"twenty":-22.055719,"median":-20.885889,"eighty":-4.981646,"marketCap":1039887195},{"date":"2023-02-10","current":27.186532,"twenty":-22.037344,"median":-20.873676,"eighty":-4.977626,"marketCap":1027653228},{"date":"2023-02-17","current":28.847843,"twenty":-22.035695,"median":-20.845796,"eighty":-4.96732,"marketCap":1088823063},{"date":"2023-02-24","current":29.876152,"twenty":-22.029478,"median":-20.834633,"eighty":-4.95567,"marketCap":1115737790},{"date":"2023-03-03","current":27.302811,"twenty":-22.012361,"median":-20.798477,"eighty":-4.893553,"marketCap":1024390836},{"date":"2023-03-10","current":28.150355,"twenty":-21.957814,"median":-20.782106,"eighty":-4.871727,"marketCap":1062723933},{"date":"2023-03-17","current":28.619298,"twenty":-21.954448,"median":-20.755321,"eighty":-4.837995,"marketCap":1079851487},{"date":"2023-03-24","current":29.32388,"twenty":-21.934194,"median":-20.729118,"eighty":3.771219,"marketCap":1116553388},{"date":"2023-03-31","current":-12.752993,"twenty":-21.910612,"median":-20.706276,"eighty":3.835525,"marketCap":1081482682},{"date":"2023-04-06","current":-12.88881,"twenty":-21.90985,"median":-20.697321,"eighty":3.835227,"marketCap":1098610236},{"date":"2023-04-14","current":-12.801571,"twenty":-21.899263,"median":-20.678231,"eighty":3.825059,"marketCap":1104319421},{"date":"2023-04-21","current":-14.947443,"twenty":-21.850993,"median":-20.670206,"eighty":3.781482,"marketCap":1279672948},{"date":"2023-04-28","current":-13.55748,"twenty":-21.838695,"median":-20.645111,"eighty":3.746421,"marketCap":1166304854},{"date":"2023-05-05","current":-13.247519,"twenty":-21.837737,"median":-20.628022,"eighty":-3.085842,"marketCap":1137758931},{"date":"2023-05-12","current":-13.196444,"twenty":-21.830658,"median":-20.620294,"eighty":-4.801486,"marketCap":1124709366},{"date":"2023-05-19","current":-11.577513,"twenty":-21.820243,"median":-20.614435,"eighty":-4.83115,"marketCap":973024741},{"date":"2023-05-26","current":-12.873913,"twenty":-21.775441,"median":-20.581853,"eighty":-4.843609,"marketCap":1077686226},{"date":"2023-06-02","current":-13.4553,"twenty":-21.758764,"median":-20.576071,"eighty":-4.84735,"marketCap":1127563965},{"date":"2023-06-09","current":-11.336689,"twenty":-21.717141,"median":-20.565455,"eighty":-4.85482,"marketCap":953400713},{"date":"2023-06-16","current":-11.670779,"twenty":-21.688764,"median":-20.543917,"eighty":-4.866541,"marketCap":995114272},{"date":"2023-06-23","current":-11.565622,"twenty":-21.678904,"median":-20.533873,"eighty":-4.872917,"marketCap":989390525},{"date":"2023-06-30","current":-11.66219,"twenty":-21.66693,"median":-20.521238,"eighty":-4.875603,"marketCap":991025881},{"date":"2023-07-07","current":-11.380237,"twenty":-21.664978,"median":-20.517651,"eighty":-4.879205,"marketCap":964860181},{"date":"2023-07-14","current":-11.034638,"twenty":-21.662538,"median":-20.509733,"eighty":-4.882597,"marketCap":964042503},{"date":"2023-07-21","current":-11.170865,"twenty":-21.660191,"median":-20.495236,"eighty":-4.893553,"marketCap":971810445},{"date":"2023-07-28","current":-11.009662,"twenty":-21.656236,"median":-20.47859,"eighty":-4.916273,"marketCap":944418228},{"date":"2023-08-04","current":-10.763767,"twenty":-21.630704,"median":-20.475882,"eighty":-4.940196,"marketCap":919887885},{"date":"2023-08-11","current":-3.964027,"twenty":-21.619037,"median":-20.452843,"eighty":-4.879205,"marketCap":906805035},{"date":"2023-08-18","current":-4.026987,"twenty":-21.613502,"median":-20.440967,"eighty":-4.848908,"marketCap":909683857},{"date":"2023-08-25","current":-4.022548,"twenty":-21.606196,"median":-20.428933,"eighty":-4.792358,"marketCap":904744397},{"date":"2023-09-01","current":-3.768342,"twenty":-21.593859,"median":-20.420865,"eighty":-4.019699,"marketCap":848763852},{"date":"2023-09-08","current":-3.73793,"twenty":-21.590181,"median":-20.408566,"eighty":-4.001992,"marketCap":830652499},{"date":"2023-09-15","current":-3.712765,"twenty":-21.579562,"median":-20.380574,"eighty":-3.942259,"marketCap":822420066},{"date":"2023-09-22","current":-3.650753,"twenty":-21.575135,"median":-20.368501,"eighty":-3.858715,"marketCap":808424930},{"date":"2023-09-29","current":-3.421608,"twenty":-21.572125,"median":-20.356574,"eighty":-3.838428,"marketCap":750797898},{"date":"2023-10-06","current":-3.012194,"twenty":-21.570144,"median":-20.353296,"eighty":-3.76226,"marketCap":658594648},{"date":"2023-10-13","current":-2.686479,"twenty":-21.569768,"median":-20.346082,"eighty":-3.707338,"marketCap":588618966},{"date":"2023-10-20","current":-2.811146,"twenty":-21.56948,"median":-20.312815,"eighty":-3.654052,"marketCap":617432482},{"date":"2023-10-27","current":-2.375367,"twenty":-21.568992,"median":-20.309123,"eighty":-3.646351,"marketCap":519466528},{"date":"2023-11-03","current":-3.917302,"twenty":-21.567321,"median":-20.299111,"eighty":-3.544741,"marketCap":863582232},{"date":"2023-11-10","current":-3.597007,"twenty":-21.566303,"median":-20.266499,"eighty":-3.604286,"marketCap":800192497},{"date":"2023-11-17","current":-3.627589,"twenty":-21.562197,"median":-20.256213,"eighty":-3.537462,"marketCap":818303850},{"date":"2023-11-24","current":-3.529793,"twenty":-21.562057,"median":-20.239654,"eighty":-3.489083,"marketCap":799369254},{"date":"2023-12-01","current":-3.547582,"twenty":-21.5525,"median":-20.141357,"eighty":-3.52171,"marketCap":803485470},{"date":"2023-12-08","current":-3.307014,"twenty":-21.542769,"median":-20.122709,"eighty":-3.489083,"marketCap":740918979},{"date":"2023-12-15","current":-3.69562,"twenty":-21.533656,"median":-20.083807,"eighty":-3.52171,"marketCap":843824392},{"date":"2023-12-22","current":-4.035423,"twenty":-21.527619,"median":-20.01593,"eighty":-3.522576,"marketCap":921209263},{"date":"2023-12-29","current":-4.090708,"twenty":-21.52655,"median":-19.978248,"eighty":-3.526906,"marketCap":940967103},{"date":"2024-01-05","current":-4.344468,"twenty":-21.525358,"median":-19.920067,"eighty":-3.533351,"marketCap":988715215},{"date":"2024-01-12","current":-6.195434,"twenty":-21.52344,"median":-19.753335,"eighty":-3.548025,"marketCap":1408569303},{"date":"2024-01-19","current":-6.4217,"twenty":-21.52344,"median":-15.556029,"eighty":-3.549796,"marketCap":1448908225},{"date":"2024-01-26","current":-8.782403,"twenty":-21.52096,"median":-14.109091,"eighty":-3.557352,"marketCap":1976607187},{"date":"2024-02-02","current":-7.600825,"twenty":-21.513689,"median":-13.749102,"eighty":-3.569428,"marketCap":1712346084},{"date":"2024-02-09","current":-7.207212,"twenty":-21.513575,"median":-13.613957,"eighty":-3.588398,"marketCap":1611087157},{"date":"2024-02-16","current":-7.247938,"twenty":-21.506276,"median":-13.555523,"eighty":-3.597007,"marketCap":1619319590},{"date":"2024-02-23","current":-8.32854,"twenty":-21.504386,"median":-13.501613,"eighty":-3.6123,"marketCap":1870809159},{"date":"2024-03-01","current":-11.523207,"twenty":-21.501535,"median":-13.4553,"eighty":-3.617449,"marketCap":2038881713},{"date":"2024-03-08","current":-10.554531,"twenty":-21.497487,"median":-13.312518,"eighty":-3.621659,"marketCap":1867487103},{"date":"2024-03-15","current":-11.064095,"twenty":-21.496624,"median":-13.247519,"eighty":-3.626597,"marketCap":1957647810},{"date":"2024-03-22","current":-11.326445,"twenty":-21.490766,"median":-13.177305,"eighty":-3.630464,"marketCap":2004067183},{"date":"2024-03-28","current":-11.452575,"twenty":-21.477499,"median":-13.148196,"eighty":-3.631217,"marketCap":2026384190},{"date":"2024-04-05","current":-10.801745,"twenty":-21.466803,"median":-12.946408,"eighty":-3.632099,"marketCap":1911228436},{"date":"2024-04-12","current":-10.055058,"twenty":-21.461539,"median":-12.894895,"eighty":-3.633023,"marketCap":1779111758},{"date":"2024-04-19","current":-9.807844,"twenty":-21.456824,"median":-12.873913,"eighty":-3.633343,"marketCap":1735370425},{"date":"2024-04-26","current":-10.816881,"twenty":-21.455182,"median":-12.8124,"eighty":-3.637723,"marketCap":1913906477},{"date":"2024-05-03","current":-11.469203,"twenty":-21.453725,"median":-12.730824,"eighty":-3.642957,"marketCap":2029326298},{"date":"2024-05-10","current":-8.594704,"twenty":-21.447775,"median":-12.51454,"eighty":-3.64496,"marketCap":1965488386},{"date":"2024-05-17","current":-7.883065,"twenty":-21.443062,"median":-12.154706,"eighty":-3.648552,"marketCap":1802746667},{"date":"2024-05-24","current":-7.51567,"twenty":-21.440467,"median":-11.944691,"eighty":-3.653227,"marketCap":1718728474},{"date":"2024-05-31","current":-7.287445,"twenty":-21.438765,"median":-11.913972,"eighty":-3.657432,"marketCap":1666536719},{"date":"2024-06-07","current":-7.712415,"twenty":-21.436028,"median":-11.820873,"eighty":-3.667469,"marketCap":1763721366},{"date":"2024-06-14","current":-7.649457,"twenty":-21.431796,"median":-11.712329,"eighty":-3.679697,"marketCap":1749323640},{"date":"2024-06-21","current":-6.779842,"twenty":-21.425982,"median":-11.674804,"eighty":-3.69138,"marketCap":1550455058},{"date":"2024-06-28","current":-7.688806,"twenty":-21.424034,"median":-11.670779,"eighty":-3.693076,"marketCap":1758322219},{"date":"2024-07-05","current":-7.869811,"twenty":-21.420068,"median":-11.629156,"eighty":-3.69699,"marketCap":1799715680},{"date":"2024-07-12","current":-8.259367,"twenty":-21.415476,"median":-11.571568,"eighty":-3.704241,"marketCap":1888801606},{"date":"2024-07-15","current":-7.818658,"twenty":-21.415058,"median":-11.565622,"eighty":-3.706013,"marketCap":1788017528},{"date":"2024-08-02","current":-6.78968,"twenty":-21.414641,"median":-11.56183,"eighty":-3.707784,"marketCap":1552704702},{"date":"2024-08-09","current":-6.633158,"twenty":-21.412151,"median":-11.523207,"eighty":-3.71219,"marketCap":1521659607},{"date":"2024-08-16","current":-6.431294,"twenty":-21.410928,"median":-11.485219,"eighty":-3.714995,"marketCap":1475351701},{"date":"2024-08-23","current":-6.486229,"twenty":-21.403699,"median":-11.452575,"eighty":-3.729351,"marketCap":1487953851},{"date":"2024-08-30","current":-6.3175,"twenty":-21.396025,"median":-11.40917,"eighty":-3.756177,"marketCap":1449247247},{"date":"2024-09-06","current":-6.35674,"twenty":-21.393924,"median":-11.355092,"eighty":-3.77086,"marketCap":1458248783},{"date":"2024-09-13","current":-6.278261,"twenty":-21.387534,"median":-11.326445,"eighty":-3.775122,"marketCap":1440245712},{"date":"2024-09-20","current":-6.301805,"twenty":-21.376871,"median":-11.275775,"eighty":-3.783142,"marketCap":1445646633},{"date":"2024-09-27","current":-6.211555,"twenty":-21.365168,"median":-11.250767,"eighty":-3.799975,"marketCap":1424943101},{"date":"2024-10-04","current":-6.894316,"twenty":-21.350709,"median":-11.235632,"eighty":-3.813963,"marketCap":1581569822},{"date":"2024-10-11","current":-6.913935,"twenty":-21.347524,"median":-11.180631,"eighty":-3.822859,"marketCap":1586070590},{"date":"2024-10-18","current":-7.467207,"twenty":-21.343075,"median":-11.167175,"eighty":-3.825993,"marketCap":1712992243},{"date":"2024-10-25","current":-7.400501,"twenty":-21.342938,"median":-11.154909,"eighty":-3.828323,"marketCap":1697689633},{"date":"2024-10-31","current":-7.063044,"twenty":-21.342346,"median":-11.153652,"eighty":-3.831162,"marketCap":1620276426},{"date":"2024-11-08","current":-10.245268,"twenty":-21.340032,"median":-11.119592,"eighty":-3.843127,"marketCap":2037947682},{"date":"2024-11-15","current":-11.597233,"twenty":-21.336418,"median":-11.153652,"eighty":-3.852751,"marketCap":2306875223},{"date":"2024-11-22","current":-9.344667,"twenty":-21.331041,"median":-11.139145,"eighty":-3.855094,"marketCap":1858803744},{"date":"2024-11-29","current":-9.219266,"twenty":-21.330759,"median":-11.119592,"eighty":-3.856223,"marketCap":1833859559},{"date":"2024-12-06","current":-8.392551,"twenty":-21.326314,"median":-11.114547,"eighty":-3.859338,"marketCap":1669412707},{"date":"2024-12-13","current":-11.652967,"twenty":-21.305987,"median":-11.115575,"eighty":-3.87719,"marketCap":2317961528},{"date":"2024-12-20","current":-11.824812,"twenty":-21.294475,"median":-11.119592,"eighty":-3.877993,"marketCap":2352144301},{"date":"2024-12-27","current":-12.182436,"twenty":-21.26507,"median":-11.153652,"eighty":-3.894887,"marketCap":2423281422},{"date":"2025-01-03","current":-13.971232,"twenty":-21.256167,"median":-11.154909,"eighty":-3.910026,"marketCap":2779101565},{"date":"2025-01-10","current":-13.750577,"twenty":-21.252461,"median":-11.164306,"eighty":-3.918163,"marketCap":2735209745},{"date":"2025-01-17","current":-12.604247,"twenty":-21.239434,"median":-11.175748,"eighty":-3.920305,"marketCap":2507186388},{"date":"2025-01-24","current":-12.485847,"twenty":-21.225631,"median":-11.191789,"eighty":-3.922976,"marketCap":2483634680},{"date":"2025-01-31","current":-11.716245,"twenty":-21.222143,"median":-11.235632,"eighty":-3.931982,"marketCap":2330548577},{"date":"2025-02-07","current":-11.355662,"twenty":-21.212096,"median":-11.250762,"eighty":-3.948487,"marketCap":2258822920},{"date":"2025-02-14","current":-10.440751,"twenty":-21.20829,"median":-11.235632,"eighty":-3.960565,"marketCap":2076832448},{"date":"2025-02-21","current":-10.225478,"twenty":-21.200156,"median":-11.183444,"eighty":-3.964027,"marketCap":2034011161},{"date":"2025-02-28","current":-9.504592,"twenty":-21.195343,"median":-11.175748,"eighty":-3.98226,"marketCap":2296290448},{"date":"2025-03-07","current":-10.681871,"twenty":-21.178962,"median":-11.164306,"eighty":-3.997428,"marketCap":2580718582},{"date":"2025-03-14","current":-10.718234,"twenty":-21.176077,"median":-11.154835,"eighty":-4.003133,"marketCap":2589504006},{"date":"2025-03-21","current":-10.940963,"twenty":-21.161863,"median":-11.124637,"eighty":-4.016201,"marketCap":2643314734},{"date":"2025-03-28","current":-10.186414,"twenty":-21.161406,"median":-11.118097,"eighty":-4.018359,"marketCap":2461017166},{"date":"2025-04-04","current":-8.181858,"twenty":-21.151111,"median":-11.108408,"eighty":-4.019699,"marketCap":1976720616},{"date":"2025-04-11","current":-6.772761,"twenty":-21.131171,"median":-11.085541,"eighty":-4.022548,"marketCap":1636285398},{"date":"2025-04-17","current":-7.286399,"twenty":-21.131171,"median":-11.049366,"eighty":-4.026099,"marketCap":1760379526},{"date":"2025-04-25","current":-7.940948,"twenty":-21.129921,"median":-11.009301,"eighty":-4.031104,"marketCap":1918517175},{"date":"2025-05-02","current":-9.10459,"twenty":-21.123639,"median":-10.998302,"eighty":-4.034765,"marketCap":2199650774},{"date":"2025-05-09","current":-11.536892,"twenty":-21.121629,"median":-10.997201,"eighty":-4.055194,"marketCap":2161528945},{"date":"2025-05-16","current":-11.205615,"twenty":-21.120569,"median":-10.998302,"eighty":-4.084594,"marketCap":2099461659},{"date":"2025-05-23","current":-10.953938,"twenty":-21.111476,"median":-11.006409,"eighty":-4.290374,"marketCap":2052307975},{"date":"2025-05-30","current":-10.564438,"twenty":-21.108578,"median":-10.998097,"eighty":-4.342797,"marketCap":1979332035},{"date":"2025-06-06","current":-11.690992,"twenty":-21.105474,"median":-11.002458,"eighty":-4.35749,"marketCap":2190400908},{"date":"2025-06-13","current":-12.601823,"twenty":-21.102061,"median":-11.009662,"eighty":-4.386985,"marketCap":2361052337}],"updateTime":1750121793210}}}